Furthermore, recent studies demonstrate the ability of myocardial velocities and deformation to detect abnormalities related to genetic disease [35], [36] In a recent study of Caiffa et al. on a very limited number of NF-1 patients (n = 17) treated with Selumetinib, subtle changes were identified in GLS compared to healthy controls. The gene discussed is NF1; the disease is hereditary disease.